Callitas Health Inc. Share Price Deutsche Boerse AG
Equities
T3F3
CA13125C1068
Biotechnology & Medical Research
Sales 2018 | 0.75 0.69 59.01 | Sales 2019 | 0.71 0.65 55.78 | Capitalization | 3.53M 3.25M 277M |
---|---|---|---|---|---|
Net income 2018 | -5M -4.61M -393M | Net income 2019 | -1M -921K -78.67M | EV / Sales 2018 | 4,852,616 x |
Net Debt 2018 | 319K 294K 25.09M | Net Debt 2019 | 848K 781K 66.68M | EV / Sales 2019 | 6,168,166 x |
P/E ratio 2018 |
-0.6
x | P/E ratio 2019 |
-1.97
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 72.04% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 02/01/18 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 30/11/14 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
1st Jan change | Capi. | |
---|---|---|
+44.48% | 54.04B | |
+43.57% | 41.96B | |
-0.86% | 41.92B | |
-7.59% | 28.35B | |
+12.30% | 26.35B | |
-21.83% | 19B | |
+7.15% | 13B | |
+29.40% | 12.28B | |
+25.15% | 12.19B |